NOP56 Gene Spinocerebellar Ataxia Type 36 Autosomal Dominant Genetic Test sale cost 4400 AED
PPP2R2B Gene Spinocerebellar Ataxia Type 12 Autosomal Dominant Genetic Test sale cost 4400 AED PPP2R2B Gene Spinocerebellar Ataxia Type 12 Autosomal Dominant Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
COL12A1 Gene Ullrich Congenital Muscular Dystrophy Type 2 Genetic Test sale cost 4400 AED COL12A1 Gene Ullrich Congenital Muscular Dystrophy Type 2 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

NOP56 Gene Spinocerebellar Ataxia Type 36 Autosomal Dominant Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The NOP56 gene is associated with Spinocerebellar Ataxia Type 36 (SCA36), a neurological disorder characterized by progressive coordination and balance difficulties due to cerebellar degeneration. This condition is inherited in an autosomal dominant manner, meaning that having just one copy of the altered gene in each cell is sufficient to cause the disorder.

DNA Labs UAE offers a specialized genetic test to identify mutations in the NOP56 gene, aiding in the diagnosis of SCA36. This test is crucial for individuals with a family history of the condition or those exhibiting symptoms, as it provides definitive genetic evidence of SCA36. Early diagnosis through genetic testing can facilitate better management and intervention strategies, potentially improving quality of life.

The cost of the NOP56 gene test for Spinocerebellar Ataxia Type 36 at DNA Labs UAE is 4400 AED. This investment includes the collection of a DNA sample, usually through a blood draw or cheek swab, and comprehensive analysis to detect the presence of specific genetic mutations associated with the disorder. Results from this test can also provide valuable information for family planning and the assessment of risk for offspring.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

NOP56 Gene Spinocerebellar ataxia type 36 autosomal dominant Genetic Test

Are you or your family members at risk of developing Spinocerebellar ataxia type 36 (SCA36)? DNA Labs UAE offers the NOP56 Gene Spinocerebellar ataxia type 36 autosomal dominant Genetic Test to provide a definitive diagnosis and determine the risk of developing this condition.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the NOP56 Gene Spinocerebellar ataxia type 36 autosomal dominant Genetic Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with SCA36.

Test Details

The NOP56 gene is associated with a specific type of spinocerebellar ataxia called spinocerebellar ataxia type 36 (SCA36). This type of ataxia is inherited in an autosomal dominant manner, meaning that a mutation in one copy of the NOP56 gene is sufficient to cause the condition.

NGS genetic testing, also known as Next-Generation Sequencing, is a high-throughput DNA sequencing technology that allows for the simultaneous analysis of multiple genes. In the context of SCA36, NGS genetic testing can identify mutations in the NOP56 gene that may be responsible for the development of the disease.

The purpose of this genetic test is to provide a definitive diagnosis of SCA36 and determine if other family members are at risk of developing the condition. It can also assist in genetic counseling and family planning decisions.

It is important to note that genetic testing for SCA36 should be conducted by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.

Test Name NOP56 Gene Spinocerebellar ataxia type 36 autosomal dominant Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for NOP56 Gene Spinocerebellar ataxia type 36, autosomal dominant NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with NOP56 Gene Spinocerebellar ataxia type 36, autosomal dominant
Test Details

The NOP56 gene is associated with a specific type of spinocerebellar ataxia called spinocerebellar ataxia type 36 (SCA36). This type of ataxia is inherited in an autosomal dominant manner, which means that a mutation in one copy of the NOP56 gene is enough to cause the condition.

NGS genetic testing refers to Next-Generation Sequencing, a high-throughput DNA sequencing technology that allows for the analysis of multiple genes simultaneously. In the context of SCA36, NGS genetic testing can be used to identify mutations in the NOP56 gene that may be responsible for the development of the disease.

The purpose of this genetic test is to provide a definitive diagnosis of SCA36, as well as to determine if other family members may be at risk of developing the condition. It can also help in genetic counseling and family planning decisions.

It is important to note that genetic testing for SCA36 should be conducted by a qualified healthcare professional or genetic counselor who can interpret the results and provide appropriate guidance and support.

SKU: TEST-2075 Category:

Related products